Keywords: actos, takes, lead, new, prescriptions, takeda, says

Actos takes the lead in new prescriptions

Article | 13 April 2000

Takeda says that its antidiabetic agent Actos (pioglitazone), whichit co-promotes with Eli Lilly, "has been the leading thiazolidinedione for new ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lilly

Go to company listing

Related Drugs

Actos

Pioglitazone

Rezulin

Avandia

rosiglitazone

Go to drug listing